Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myeloid Leukemias”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01713582
What this trial is testing

A Dose-finding Study of the Bromodomain (Brd) Inhibitor OTX015/ Birabresib (MK-8628) in Hematologic Malignancies (MK-8628-001)

Who this might be right for
Acute Myeloid LeukemiaDiffuse Large B-cell LymphomaAcute Lymphoblastic Leukemia+1 more
Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 141
Testing effectiveness (Phase 2)WithdrawnNCT00002761
What this trial is testing

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Columbia University
Large-scale testing (Phase 3)Study completedNCT01015196
What this trial is testing

Prospective Randomized Study Comparing One or Two High Dose Chemotherapy Regimen Followed by Autologous Stem Cell Transplantation

Who this might be right for
Acute Myeloid Leukemia
Nantes University Hospital 832
Testing effectiveness (Phase 2)Study completedNCT00045396
What this trial is testing

A Phase II Study Of The Farnesyltransferase Inhibitor ZANESTRA (R115777, NSC #702818, IND #58,359) In Complete Remission Following Induction And/Or Consolidation Chemotherapy In Adults With Poor-Risk Acute Myelogenous Leukemia (AML) And High-Risk Myelodysplasia (MDS)

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+6 more
National Cancer Institute (NCI)
Early research (Phase 1)Active Not RecruitingNCT05552469
What this trial is testing

Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases

Who this might be right for
Myeloid Diseases
Novartis Pharmaceuticals 71
Not applicableLooking for participantsNCT06710418
What this trial is testing

Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia

Who this might be right for
Acute Myeloid LeukemiaB Acute Lymphoblastic LeukemiaB Lymphoblastic Lymphoma+1 more
University of Washington 50
Not applicableLooking for participantsNCT06229860
What this trial is testing

Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts w/Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid LeukemiaChronic Phase Chronic Myelogenous Leukemia
University of California, Irvine 75
Testing effectiveness (Phase 2)Study completedNCT02044796
What this trial is testing

Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

Who this might be right for
Acute Biphenotypic Leukemiade Novo Myelodysplastic SyndromePreviously Treated Myelodysplastic Syndrome+3 more
Fred Hutchinson Cancer Center 199
Testing effectiveness (Phase 2)Study completedNCT01056523
What this trial is testing

Use of Ribavirin and Low Dose Ara-C to Treat Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Jewish General Hospital 29
Not applicableNot Yet RecruitingNCT07751588
What this trial is testing

Plasma ctDNA Monitoring in Pediatric Acute Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, China 25
Large-scale testing (Phase 3)Study completedNCT00574873
What this trial is testing

Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML

Who this might be right for
Chronic Myeloid Leukemia
Pfizer 502
Testing effectiveness (Phase 2)Study completedNCT00037596
What this trial is testing

Study Evaluating Gemtuzumab Ozogamicin in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Wyeth is now a wholly owned subsidiary of Pfizer
Early research (Phase 1)Active Not RecruitingNCT05362773
What this trial is testing

MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies

Who this might be right for
Leukemia, Acute MyeloidMyelodysplastic SyndromesClassical Hodgkin Lymphoma+5 more
MacroGenics 130
Testing effectiveness (Phase 2)Study completedNCT00315705
What this trial is testing

Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias.

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaRelapsed Leukemia
Genzyme, a Sanofi Company 50
Early research (Phase 1)Study completedNCT04126707
What this trial is testing

The Absorption, Metabolism and Excretion of [14C] HQP1351 in Humans

Who this might be right for
Chronic Myeloid Leukemia (CML)
Ascentage Pharma Group Inc. 6
Early research (Phase 1)Ended earlyNCT05209152
What this trial is testing

AMG 176 With Azacitidine in Subjects With Myelodysplastic Syndrome /Chronic Myelomonocytic Leukemia

Who this might be right for
Higher Risk Myelodysplastic SyndromeChronic Myelomonocytic Leukemia
Amgen 7
Large-scale testing (Phase 3)Looking for participantsNCT06756152
What this trial is testing

Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with Hemoblastosis

Who this might be right for
Biphenotypic Acute LeukemiaAcute Lymphoblastic LeukemiaMyeloblastic Leukemia+3 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 50
Testing effectiveness (Phase 2)Study completedNCT00047021
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or Lymphoma

Who this might be right for
LeukemiaLymphoma
Case Comprehensive Cancer Center 3
Early research (Phase 1)Ended earlyNCT05038644
What this trial is testing

XmAb18968 (CD3-CD38) in Relapsed or Refractory Acute Leukemia and T Cell Lymphoblastic Leukemia

Who this might be right for
Acute Myeloid LeukemiaT Cell Acute Lymphoblastic LeukemiaT Cell Lymphoblastic Lymphoma
Ehab L Atallah 22
Testing effectiveness (Phase 2)Study completedNCT03836209
What this trial is testing

Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
PrECOG, LLC. 181
Next Page
44